Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients.
Eur J Cancer
; 76: 188-196, 2017 05.
Article
in En
| MEDLINE
| ID: mdl-28329731
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thoracic Neoplasms
/
3-Iodobenzylguanidine
/
Myeloablative Agonists
/
Stem Cell Transplantation
/
Induction Chemotherapy
/
Abdominal Neoplasms
/
Neuroblastoma
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Newborn
Language:
En
Journal:
Eur J Cancer
Year:
2017
Document type:
Article